# GD2 CAR-T CELL THERAPY CLINICAL TRIAL SITE ADMINISTRATION AND CELL DISTRIBUTION LOGISTICS

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2020 · $1,247,433

## Abstract

Support to manage cellular product distribution logistics for an autologous CAR T-cell study in pediatric neuroblastoma and osteosarcoma.

## Key facts

- **NIH application ID:** 10281330
- **Project number:** 75N91019D00024-0-759102000020-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** ETHAN DMITROVSKY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,247,433
- **Award type:** —
- **Project period:** 2020-09-28 → 2025-09-27

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10281330

## Citation

> US National Institutes of Health, RePORTER application 10281330, GD2 CAR-T CELL THERAPY CLINICAL TRIAL SITE ADMINISTRATION AND CELL DISTRIBUTION LOGISTICS (75N91019D00024-0-759102000020-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10281330. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*